Reduction of Antiarrhythmic Drug Use in Patients Receiving Implantable Cardioverter Defibrillators
- 1 January 1996
- journal article
- Published by Wiley in Pacing and Clinical Electrophysiology
- Vol. 19 (1) , 61-64
- https://doi.org/10.1111/j.1540-8159.1996.tb04791.x
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Interactions between drugs and devices: Experimental and clinical studiesAmerican Heart Journal, 1994
- Clinical predictors of implantable cardioverter-defibrillator shocks (results of the CASCADE trial)The American Journal of Cardiology, 1994
- Effect of the Antiarrhythmic Agent Moricizine on Survival after Myocardial InfarctionNew England Journal of Medicine, 1992
- Survival after implantation of the cardioverter defibrillatorThe American Journal of Cardiology, 1992
- Quinidine-related mortality in the short-to-medium-term treatment of ventricular arrhythmias. A meta-analysis.Circulation, 1991
- Predictors of first discharge and subsequent survival in patients with automatic implantable cardioverter-defibrillators.Circulation, 1991
- Mortality and Morbidity in Patients Receiving Encainide, Flecainide, or PlaceboNew England Journal of Medicine, 1991